infliximab
janssen
[' psa', '#1112', 'axspa', 'danbio', 'imab ']
danbio registry: 1600+ pts ra, axspa, psa infiximab biosimilar to biosimilar switch (ct-p13 -&gt; gp1111) maintenance at 1yr:
&gt;80%
&gt; withdrawal in original ifx naive, but higher bl da do second time switchers do better because of past switch experience? abs#1112 #acr22 
MD, PhD Institute of Infection and Immunity @UofGlasgow UK. Past Co-chair of @EULAR Synovitis Study Group. CrossFit athlete and Mountains lover. Views my own.